Deutsche Bank’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.13M | Buy |
118,550
+5,231
| +5% | +$266K | ﹤0.01% | 1219 |
|
|
2025
Q4 | $5.63M | Buy |
113,319
+965
| +0.9% | +$46.9K | ﹤0.01% | 1253 |
|
|
2025
Q3 | $5.37M | Buy |
112,354
+67,718
| +152% | +$2.73M | ﹤0.01% | 1284 |
|
|
2025
Q2 | $1.41M | Sell |
44,636
-2,181
| -5% | -$69.9K | ﹤0.01% | 1905 |
|
|
2025
Q1 | $1.53M | Sell |
46,817
-58,766
| -56% | -$2.08M | ﹤0.01% | 1915 |
|
|
2024
Q4 | $3.82M | Buy |
105,583
+73,213
| +226% | +$2.58M | ﹤0.01% | 1470 |
|
|
2024
Q3 | $1.01M | Buy |
32,370
+6,711
| +26% | +$209K | ﹤0.01% | 2109 |
|
|
2024
Q2 | $686K | Sell |
25,659
-5,294
| -17% | -$153K | ﹤0.01% | 2178 |
|
|
2024
Q1 | $1.06M | Buy |
30,953
+4,308
| +16% | +$128K | ﹤0.01% | 1992 |
|
|
2023
Q4 | $771K | Sell |
26,645
-659
| -2% | -$17.5K | ﹤0.01% | 2163 |
|
|
2023
Q3 | $753K | Buy |
27,304
+3,082
| +13% | +$93.8K | ﹤0.01% | 1901 |
|
|
2023
Q2 | $728K | Sell |
24,222
-9,711
| -29% | -$340K | ﹤0.01% | 2155 |
|
|
2023
Q1 | $1.23M | Buy |
33,933
+9,283
| +38% | +$357K | ﹤0.01% | 1976 |
|
|
2022
Q4 | $879K | Buy |
24,650
+2,503
| +11% | +$87K | ﹤0.01% | 2136 |
|
|
2022
Q3 | $749K | Sell |
22,147
-43,567
| -66% | -$1.42M | ﹤0.01% | 2147 |
|
|
2022
Q2 | $1.9M | Sell |
65,714
-163,970
| -71% | -$4.7M | ﹤0.01% | 1791 |
|
|
2022
Q1 | $7.42M | Sell |
229,684
-53,991
| -19% | -$1.66M | ﹤0.01% | 1215 |
|
|
2021
Q4 | $8.27M | Buy |
283,675
+27,725
| +11% | +$841K | ﹤0.01% | 1188 |
|
|
2021
Q3 | $6.83M | Sell |
255,950
-113,678
| -31% | -$3.05M | ﹤0.01% | 1345 |
|
|
2021
Q2 | $11.4M | Buy |
369,628
+115,840
| +46% | +$3.55M | 0.01% | 1123 |
|
|
2021
Q1 | $6.64M | Buy |
253,788
+4,723
| +2% | +$132K | ﹤0.01% | 1400 |
|
|
2020
Q4 | $6.27M | Buy |
249,065
+42,550
| +21% | +$916K | ﹤0.01% | 1251 |
|
|
2020
Q3 | $4.3M | Sell |
206,515
-68,390
| -25% | -$1.55M | ﹤0.01% | 1326 |
|
|
2020
Q2 | $6.53M | Buy |
274,905
+147,445
| +116% | +$3.26M | 0.01% | 1167 |
|
|
2020
Q1 | $2.29M | Sell |
127,460
-248,610
| -66% | -$5.22M | ﹤0.01% | 1629 |
|
|
2019
Q4 | $8.92M | Buy |
376,070
+13,450
| +4% | +$327K | 0.01% | 1146 |
|
|
2019
Q3 | $9.96M | Sell |
362,620
-71,377
| -16% | -$2.11M | 0.01% | 1076 |
|
|
2019
Q2 | $14.4M | Sell |
433,997
-27,774
| -6% | -$952K | 0.01% | 1143 |
|
|
2019
Q1 | $16.2M | Sell |
461,771
-35,344
| -7% | -$1.32M | 0.01% | 1092 |
|
|
2018
Q4 | $16.5M | Sell |
497,115
-113,641
| -19% | -$4.89M | 0.01% | 993 |
|
|
2018
Q3 | $30.8M | Sell |
610,756
-195,145
| -24% | -$9.64M | 0.02% | 891 |
|
|
2018
Q2 | $48.2M | Buy |
805,901
+590,130
| +273% | +$30.6M | 0.02% | 691 |
|
|
2018
Q1 | $9.88M | Buy |
215,771
+35,538
| +20% | +$1.48M | ﹤0.01% | 1629 |
|
|
2017
Q4 | $7.18M | Sell |
180,233
-158,459
| -47% | -$6.26M | ﹤0.01% | 1736 |
|
|
2017
Q3 | $13.5M | Buy |
338,692
+145,019
| +75% | +$6.28M | 0.01% | 1256 |
|
|
2017
Q2 | $8.35M | Buy |
193,673
+156,206
| +417% | +$5.56M | 0.01% | 1540 |
|
|
2017
Q1 | $1.17M | Sell |
37,467
-6,835
| -15% | -$183K | ﹤0.01% | 2550 |
|
|
2016
Q4 | $1.12M | Sell |
44,302
-23,232
| -34% | -$519K | ﹤0.01% | 2620 |
|
|
2016
Q3 | $1.67M | Sell |
67,534
-4,500
| -6% | -$102K | ﹤0.01% | 2477 |
|
|
2016
Q2 | $1.47M | Buy |
72,034
+11,190
| +18% | +$198K | ﹤0.01% | 2624 |
|
|
2016
Q1 | $926K | Sell |
60,844
-8,751
| -13% | -$114K | ﹤0.01% | 2860 |
|
|
2015
Q4 | $934K | Sell |
69,595
-41,096
| -37% | -$636K | ﹤0.01% | 2914 |
|
|
2015
Q3 | $1.55M | Sell |
110,691
-42,848
| -28% | -$797K | ﹤0.01% | 2648 |
|
|
2015
Q2 | $2.61M | Buy |
153,539
+152,162
| +11,050% | +$2.17M | ﹤0.01% | 2249 |
|
|
2015
Q1 | $15K | Sell |
1,377
-28,567
| -95% | -$270K | ﹤0.01% | 4731 |
|
|
2014
Q4 | $248K | Buy |
29,944
+5,404
| +22% | +$45.4K | ﹤0.01% | 4180 |
|
|
2014
Q3 | $212K | Buy |
24,540
+23,092
| +1,595% | +$209K | ﹤0.01% | 4033 |
|
|
2014
Q2 | $15K | Sell |
1,448
-8,682
| -86% | -$77.3K | ﹤0.01% | 5403 |
|
|
2014
Q1 | $90K | Buy |
10,130
+2,442
| +32% | +$22.5K | ﹤0.01% | 4281 |
|
|
2013
Q4 | $57K | Sell |
7,688
-51,990
| -87% | -$363K | ﹤0.01% | 4302 |
|
|
2013
Q3 | $436K | Buy |
59,678
+49,803
| +504% | +$335K | ﹤0.01% | 3609 |
|
|
2013
Q2 | $63K | Buy |
+9,875
| New | +$58.2K | ﹤0.01% | 4433 |
|
Other funds holding SUPN
VPM
VCM
NAMI
AC
Deutsche Bank's SUPN Position: Q1 2026 in Review
Deutsche Bank increased its Supernus Pharmaceuticals (SUPN) stake by 4.6% in Q1 2026, buying an estimated $266K and bringing the position to 118,550 shares worth $6.13M. The position accounts for ﹤0.01% of the portfolio, ranked #1219.
Deutsche Bank first reported a position in SUPN in Q2 2013 and has held it in 52 quarters since. The position peaked at $48.2M in Q2 2018. 327 funds tracked by Wall St. Rank hold SUPN as of Q1 2026.
- Deutsche Bank held 118,550 shares of Supernus Pharmaceuticals worth $6.13M as of Q1 2026.
- Deutsche Bank bought 5,231 Supernus Pharmaceuticals shares in Q1 2026, an estimated $266K.
- Supernus Pharmaceuticals made up ﹤0.01% of Deutsche Bank's portfolio in Q1 2026, its #1219 holding.
- Deutsche Bank first reported a position in Supernus Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- Deutsche Bank's Supernus Pharmaceuticals position peaked at $48.2M in Q2 2018.
- 327 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q1 2026.
Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.